Market Research Reports and Industry Reports

Australia Infectious Diagnostics Market Outlook to 2024

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Australia Infectious Diagnostics Market Outlook to 2024

Summary

GlobalDatas new report, Australia Infectious Diagnostics Market Outlook to 2024, provides key market data on the Australia Infectious Diagnostics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Bacteriology, Chlamydia trichomatis Diagnostic Test Kits, Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests, Hepatitis Test Kits, Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests, Infectious Diagnostics Multiple Parameter Test Kits, Infectious Diagnostics Rapid Tests & POC, Mycobacterium tuberculosis Diagnostic Tests, Nucleic Acid Testing Extraction Instruments, Other Virology, Parasitology & Mycology, Polymerase Chain Reaction (PCR) Systems, Post Streptococcus pyogenes Diagnostic Tests, Retrovirus Tests and Treponema pallidum Diagnostic Tests.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Infectious Diagnostics market segments - Bacteriology, Chlamydia trichomatis Diagnostic Test Kits, Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests, Hepatitis Test Kits, Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests, Infectious Diagnostics Multiple Parameter Test Kits, Infectious Diagnostics Rapid Tests & POC, Mycobacterium tuberculosis Diagnostic Tests, Nucleic Acid Testing Extraction Instruments, Other Virology, Parasitology & Mycology Polymerase Chain Reaction (PCR) Systems, Post Streptococcus pyogenes Diagnostic Tests, Retrovirus Tests and Treponema pallidum Diagnostic Tests.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
- 2017 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the Australia Infectious Diagnostics market.
- Key players covered include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Hologic Inc and Siemens Healthcare GmbH.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.

2
1.List of Tables 5
1.2 List of Figures 6
2 Introduction 8
2.What Is This Report About? 8
2.2 Infectious Diagnostics Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 10
3 Infectious Diagnostics Market, Australia 15
3.Infectious Diagnostics Market, Australia, Revenue ($m), 2010-2017 15
3.2 Infectious Diagnostics Market, Australia, Revenue ($m), 2017-2024 18
3.2.Chlamydia trichomatis Diagnostic Test Kits Market, Australia, Revenue ($m), by Segment, 2010-2017 21
3.2.2 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Australia, Revenue ($m), by Segment, 2010-2017 23
3.2.3 Hepatitis Test Kits Market, Australia, Revenue ($m), by Segment, 2010-2017 25
3.2.4 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Australia, Revenue ($m), by Segment, 2010-2017 27
3.2.5 Infectious Diagnostics Multiple Parameter Test Kits Market, Australia, Revenue ($m), by Segment, 2010-2017 29
3.2.6 Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), by Segment, 2010-2017 31
3.2.7 Mycobacterium tuberculosis Diagnostic Tests Market, Australia, Revenue ($m), by Segment, 2010-2017 33
3.2.8 Polymerase Chain Reaction (PCR) Systems Market, Australia, Revenue ($m), by Segment, 2010-2017 35
3.2.9 Post Streptococcus pyogenes Diagnostic Tests Market, Australia, Revenue ($m), by Segment, 2010-2017 37
3.2.10 Retrovirus Tests Market, Australia, Revenue ($m), by Segment, 2010-2017 39
3.2.1Treponema pallidum Diagnostic Tests Market, Australia, Revenue ($m), by Segment, 2010-2017 41
3.2.12 Chlamydia trichomatis Diagnostic Test Kits Market, Australia, Revenue ($m), by Segment, 2017-2024 43
3.2.13 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Australia, Revenue ($m), by Segment, 2017-2024 45
3.2.14 Hepatitis Test Kits Market, Australia, Revenue ($m), by Segment, 2017-2024 47
3.2.15 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Australia, Revenue ($m), by Segment, 2017-2024 49
3.2.16 Infectious Diagnostics Multiple Parameter Test Kits Market, Australia, Revenue ($m), by Segment, 2017-2024 51
3.2.17 Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), by Segment, 2017-2024 53
3.2.18 Mycobacterium tuberculosis Diagnostic Tests Market, Australia, Revenue ($m), by Segment, 2017-2024 55
3.2.19 Polymerase Chain Reaction (PCR) Systems Market, Australia, Revenue ($m), by Segment, 2017-2024 57
3.2.20 Post Streptococcus pyogenes Diagnostic Tests Market, Australia, Revenue ($m), by Segment, 2017-2024 59
3.2.2Retrovirus Tests Market, Australia, Revenue ($m), by Segment, 2017-2024 61
3.2.22 Treponema pallidum Diagnostic Tests Market, Australia, Revenue ($m), by Segment, 2017-2024 63
3.3 Infectious Diagnostics Market, Australia, Volume (Units), 2010-2017 65
3.4 Infectious Diagnostics Market, Australia, Volume (Units), 2017-2024 68
3.4.Chlamydia trichomatis Diagnostic Test Kits Market, Australia, Volume (Units), by Segment, 2010-2017 71
3.4.2 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Australia, Volume (Units), by Segment, 2010-2017 73
3.4.3 Hepatitis Test Kits Market, Australia, Volume (Units), by Segment, 2010-2017 75
3.4.4 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Australia, Volume (Units), by Segment, 2010-2017 77
3.4.5 Infectious Diagnostics Multiple Parameter Test Kits Market, Australia, Volume (Units), by Segment, 2010-2017 79
3.4.6 Infectious Diagnostics Rapid Tests & POC Market, Australia, Volume (Units), by Segment, 2010-2017 81
3.4.7 Mycobacterium tuberculosis Diagnostic Tests Market, Australia, Volume (Units), by Segment, 2010-2017 83
3.4.8 Polymerase Chain Reaction (PCR) Systems Market, Australia, Volume (Units), by Segment, 2010-2017 85
3.4.9 Post Streptococcus pyogenes Diagnostic Tests Market, Australia, Volume (Units), by Segment, 2010-2017 87
3.4.10 Retrovirus Tests Market, Australia, Volume (Units), by Segment, 2010-2017 89
3.4.1Treponema pallidum Diagnostic Tests Market, Australia, Volume (Units), by Segment, 2010-2017 91
3.4.12 Chlamydia trichomatis Diagnostic Test Kits Market, Australia, Volume (Units), by Segment, 2017-2024 93
3.4.13 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Australia, Volume (Units), by Segment, 2017-2024 95
3.4.14 Hepatitis Test Kits Market, Australia, Volume (Units), by Segment, 2017-2024 97
3.4.15 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Australia, Volume (Units), by Segment, 2017-2024 99
3.4.16 Infectious Diagnostics Multiple Parameter Test Kits Market, Australia, Volume (Units), by Segment, 2017-2024 101
3.4.17 Infectious Diagnostics Rapid Tests & POC Market, Australia, Volume (Units), by Segment, 2017-2024 103
3.4.18 Mycobacterium tuberculosis Diagnostic Tests Market, Australia, Volume (Units), by Segment, 2017-2024 105
3.4.19 Polymerase Chain Reaction (PCR) Systems Market, Australia, Volume (Units), by Segment, 2017-2024 107
3.4.20 Post Streptococcus pyogenes Diagnostic Tests Market, Australia, Volume (Units), by Segment, 2017-2024 109
3.4.2Retrovirus Tests Market, Australia, Volume (Units), by Segment, 2017-2024 111
3.4.22 Treponema pallidum Diagnostic Tests Market, Australia, Volume (Units), by Segment, 2017-2024 113
3.5 Infectious Diagnostics Market, Australia, Average Price ($), 2010-2024 115
3.6 Infectious Diagnostics Market, Australia, Distribution Share by Revenue ($m), 2017 121
3.7 Infectious Diagnostics Market, Australia, Company Share by Revenue ($m), 2017 122
4 Overview of Key Companies in Australia, Infectious Diagnostics Market 124
4.Abbott Laboratories 124
4.1.Company Overview 124
4.2 F. Hoffmann-La Roche Ltd 124
4.2.Company Overview 124
4.3 Hologic Inc 124
4.3.Company Overview 124
4.4 Qiagen NV 125
4.4.Company Overview 125
4.5 Becton Dickinson and Co 125
4.5.Company Overview 125
4.6 bioMerieux SA 125
4.6.Company Overview 125
4.7 Beckman Coulter Inc 125
4.7.Company Overview 125
4.8 Cepheid 126
4.8.Company Overview 126
4.9 Siemens Healthcare GmbH 126
4.9.Company Overview 126
4.10 Thermo Fisher Scientific Inc 126
4.10.Company Overview 126
4.1Seegene Inc 126
4.11.Company Overview 126
4.12 Alere Inc 127
4.12.Company Overview 127
4.13 Bioneer Corp 127
4.13.Company Overview 127
4.14 Fast-track diagnostics S.a.r.l. 127
4.14.Company Overview 127
5 Infectious Diagnostics Market Pipeline Products 128
6 Financial Deals Landscape 132
6.Partnerships 132
6.1.iBio Enters into Agreement with TheoremDx 132
6.1.2 Stellar Biotech Terminates Licensing Agreement with University of Guelph 133
7 Recent Developments 134
7.Corporate Communications 134
7.1.Sep 01, 2017: Management changes resulting from sale of DIAsource 134
7.1.2 Apr 04, 2017: GSK responds to Cyclone Debbie 134
7.1.3 Apr 03, 2017: Gordon Ballantyne to succeed Robert Cooke as Healthscope Managing Director and CEO 134
7.2 Financial Announcements 135
7.2.Oct 25, 2017: Axiron Net Sales, Quarter To 30 September 2017 135
7.2.2 Sep 01, 2017: Anteo Diagnostics: 30 June 2017 Preliminary Financial Statements 135
7.2.3 Aug 23, 2017: Healthscope 2017 Full Year Results 136
7.2.4 Jul 25, 2017: Genetic Signatures: Quarterly Cash Flow and Activities Report - 30 June 2017 138
7.3 Other Significant Developments 140
7.3.Nov 15, 2016: Genera Lodges 2016 Tax Return - To Receive $752k R&D Tax Rebate 140
8 Appendix 141
8.Research Methodology 142
8.1.Coverage 142
8.1.2 Secondary Research 142
8.1.3 Primary Research 143
8.1.4 Market Modeling and Forecasting 144
8.1.5 Company Share Analysis 145
8.1.6 Distribution Share Analysis 146
8.1.7 Benchmarking 146
8.2 GlobalData Consulting 146
8.3 Contact Us 147
8.4 Disclaimer 147

List Of Tables

1.1 List of Tables
Table 1: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 16
Table 2: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 19
Table 3: Chlamydia trichomatis Diagnostic Test Kits Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 22
Table 4: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 24
Table 5: Hepatitis Test Kits Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 26
Table 6: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 28
Table 7: Infectious Diagnostics Multiple Parameter Test Kits Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 30
Table 8: Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 32
Table 9: Mycobacterium tuberculosis Diagnostic Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 34
Table 10: Polymerase Chain Reaction (PCR) Systems Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 36
Table 11: Post Streptococcus pyogenes Diagnostic Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 38
Table 12: Retrovirus Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 40
Table 13: Treponema pallidum Diagnostic Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 42
Table 14: Chlamydia trichomatis Diagnostic Test Kits Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 44
Table 15: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 46
Table 16: Hepatitis Test Kits Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 48
Table 17: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 50
Table 18: Infectious Diagnostics Multiple Parameter Test Kits Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 52
Table 19: Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 54
Table 20: Mycobacterium tuberculosis Diagnostic Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 56
Table 21: Polymerase Chain Reaction (PCR) Systems Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 58
Table 22: Post Streptococcus pyogenes Diagnostic Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 60
Table 23: Retrovirus Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 62
Table 24: Treponema pallidum Diagnostic Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 64
Table 25: Infectious Diagnostics Market, Australia, Volume (Units), Historic, 2010-2017 66
Table 26: Infectious Diagnostics Market, Australia, Volume (Units), Forecast, 2017-2024 69
Table 27: Chlamydia trichomatis Diagnostic Test Kits Market, Australia, Volume (Units), Historic, 2010-2017 72
Table 28: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Australia, Volume (Units), Historic, 2010-2017 74
Table 29: Hepatitis Test Kits Market, Australia, Volume (Units), Historic, 2010-2017 76
Table 30: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Australia, Volume (Units), Historic, 2010-2017 78
Table 31: Infectious Diagnostics Multiple Parameter Test Kits Market, Australia, Volume (Units), Historic, 2010-2017 80
Table 32: Infectious Diagnostics Rapid Tests & POC Market, Australia, Volume (Units), Historic, 2010-2017 82
Table 33: Mycobacterium tuberculosis Diagnostic Tests Market, Australia, Volume (Units), Historic, 2010-2017 84
Table 34: Polymerase Chain Reaction (PCR) Systems Market, Australia, Volume (Units), Historic, 2010-2017 86
Table 35: Post Streptococcus pyogenes Diagnostic Tests Market, Australia, Volume (Units), Historic, 2010-2017 88
Table 36: Retrovirus Tests Market, Australia, Volume (Units), Historic, 2010-2017 90
Table 37: Treponema pallidum Diagnostic Tests Market, Australia, Volume (Units), Historic, 2010-2017 92
Table 38: Chlamydia trichomatis Diagnostic Test Kits Market, Australia, Volume (Units), Forecast, 2017-2024 94
Table 39: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Australia, Volume (Units), Forecast, 2017-2024 96
Table 40: Hepatitis Test Kits Market, Australia, Volume (Units), Forecast, 2017-2024 98
Table 41: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Australia, Volume (Units), Forecast, 2017-2024 100
Table 42: Infectious Diagnostics Multiple Parameter Test Kits Market, Australia, Volume (Units), Forecast, 2017-2024 102
Table 43: Infectious Diagnostics Rapid Tests & POC Market, Australia, Volume (Units), Forecast, 2017-2024 104
Table 44: Mycobacterium tuberculosis Diagnostic Tests Market, Australia, Volume (Units), Forecast, 2017-2024 106
Table 45: Polymerase Chain Reaction (PCR) Systems Market, Australia, Volume (Units), Forecast, 2017-2024 108
Table 46: Post Streptococcus pyogenes Diagnostic Tests Market, Australia, Volume (Units), Forecast, 2017-2024 110
Table 47: Retrovirus Tests Market, Australia, Volume (Units), Forecast, 2017-2024 112
Table 48: Treponema pallidum Diagnostic Tests Market, Australia, Volume (Units), Forecast, 2017-2024 114
Table 49: Infectious Diagnostics Market, Australia, Average Price ($) Historic, 2010-2017 115
Table 50: Infectious Diagnostics Market, Australia, Average Price ($), Forecast, 2017-2024 118
Table 51: Infectious Diagnostics Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2017 121
Table 52: Infectious Diagnostics Market, Australia, Company Share by Revenue ($m), USD Constant, 2017 123
Table 53: Infectious Diagnostics Market Pipeline Products 128
Table 54: iBio Enters into Agreement with TheoremDx 132
Table 55: Stellar Biotech Terminates Licensing Agreement with University of Guelph 133
Table 56: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 144

Caltex Australia Ltd (CTX) - Oil & Gas - Deals and Alliances Profile

Caltex Australia Limited (Caltex) is a transport fuel supplier and convenience retailer. It is the parent company of Caltex group. The company purchases, refines, distributes and markets petroleum products. It

USD 250View Report

Australia Iron Ore Market Research Report 2017

The Australia Iron Ore market is valued at 34395.47 million USD in 2016 and is expected to reach 78203.78 million USD by the end of 2022, growing at a CAGR

USD 4000View Report

Canada In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Canada In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology CultureGlobalDatas new report, Canada In Vitro

USD 5995View Report

Brazil In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Brazil In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology CultureGlobalDatas new report, Brazil In Vitro

USD 5995View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 4995
  • Site Licence    USD 9990
  • Enterprise Wide Licence    USD 14985
$ 4995

Reports Details

Published Date : Nov 2017
No. of Pages :147
Country :Australia
Category :Medical Devices
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube